P

Prime Medicine Inc
NASDAQ:PRME

Watchlist Manager
Prime Medicine Inc
NASDAQ:PRME
Watchlist
Price: 2.9 USD 3.94% Market Closed
Market Cap: 380.4m USD
Have any thoughts about
Prime Medicine Inc?
Write Note

Prime Medicine Inc
Change in Deffered Taxes

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Prime Medicine Inc
Change in Deffered Taxes Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Change in Deffered Taxes CAGR 3Y CAGR 5Y CAGR 10Y
P
Prime Medicine Inc
NASDAQ:PRME
Change in Deffered Taxes
-$279k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Change in Deffered Taxes
-$2.1B
CAGR 3-Years
-2%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Change in Deffered Taxes
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Change in Deffered Taxes
-$1.5B
CAGR 3-Years
-93%
CAGR 5-Years
-44%
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Change in Deffered Taxes
-$531.4m
CAGR 3-Years
N/A
CAGR 5-Years
18%
CAGR 10-Years
-13%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Change in Deffered Taxes
-$763.4m
CAGR 3-Years
N/A
CAGR 5-Years
-29%
CAGR 10-Years
-30%
No Stocks Found

Prime Medicine Inc
Glance View

Market Cap
380.4m USD
Industry
Biotechnology

Prime Medicine Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Cambridge, Massachusetts. The company went IPO on 2022-10-20. Prime Medicine, Inc. is a United States-based biotechnology company. The firm is engaged in multiple drug discovery programs that target liver, eye, ex-vivo hematopoietic stem cell and neuro-muscular indications. The firm's Prime Editing, a transformative technology that addressed the cause of genetic disease. The firm's collaborative approach help fight disease and accelerating the development of Prime Editing to deliver therapies for patients. Its Prime Editing is used to modify gene-regulatory sequences. These edits can be made in therapeutically relevant cells and organs, including specialized terminally differentiated cells. Its Prime Editing acts as a Deoxyribonucleic acid (DNA) word processor, with the power to search and replace genetic sequences at their exact location in the genome, all without making double-strand breaks in DNA.

PRME Intrinsic Value
1.69 USD
Overvaluation 42%
Intrinsic Value
Price
P

See Also

What is Prime Medicine Inc's Change in Deffered Taxes?
Change in Deffered Taxes
-279k USD

Based on the financial report for Dec 31, 2023, Prime Medicine Inc's Change in Deffered Taxes amounts to -279k USD.

What is Prime Medicine Inc's Change in Deffered Taxes growth rate?
Change in Deffered Taxes CAGR 1Y
71%

Over the last year, the Change in Deffered Taxes growth was 71%.

Back to Top